Moderna, Inc. - 8-K Filing
Moderna reports Q2 revenue of $145M with net loss of $(800)M but improves full-year cash outlook to $4.7-$5.2B (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $MRNA